With that thought in mind, I think this bill also points to wider issues in the way that we regulate, and other members have referred to this, saying that perhaps our Medicines Act 1981—it's older than me—should be kept as it is, or it needs a serious do-over. Actually, I would argue that New Zealand's duplication of regulatory systems, where we have our own system in parallel to Australia and the US and the EU and UK and Japan, is completely nuts. I mean, this is a supposedly First World, industrialised, developed country that is having conniptions where the leading article in the news most nights is about the shortage of a sandwich of cardboard and plaster of Paris—you can't make this up. But the fact is that because we've duplicated our regulatory systems—we've said we've got Australia standard, New Zealand standard—AS/NZS—for building products, we've got brands, and we've got the councils and architects having their 10 cents, there's only one particular type of plasterboard that's managed to run the gauntlet and get 96 percent market share. Now, they can't supply the market and we're in crisis, but, as it turns out, plasterboard is on the critical path for most building.